The catheter associated blood stream infection market comprises products such as antiseptics, disinfectants, and dressings that are used for prevention and treatment of catheter related blood stream infections. Catheter associated blood stream infections are common hospital acquired infections caused due to contaminated catheters that enter into the bloodstream. Catheters are medical devices regularly used in healthcare facilities for administration of medications, fluids, blood products and for monitoring various body functions. However, prolonged use of catheters increases the risk of infection as bacteria can enter into the blood vessels through catheters. The products available in the catheter associated blood stream infection market such as antiseptics and disinfectants effectively destroy microorganisms on catheter surfaces and prevents further transmission of infections. Dressings used over catheter insertion sites create a protective barrier against external contaminants.
The Global Catheter Associated Blood Stream Infection Market is estimated to be valued at US$ 1875.01 Mn in 2024 and is expected to exhibit a CAGR of 6.2% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in The Catheter Associated Blood Stream Infection Market are BASF SE, Croda International plc, Emery Oleochemicals, Haihang Industry Co., Ltd, Jiangsu Senxuan Pharmaceutical and Chemical Co., Ltd., Matrica S.p.A., Nantong Hengxing Electronic Materials Co., Ltd., Nantong Jinghua Pharmaceutical Co., Ltd., Wufeng Chicheng Biotech Co., Ltd., and Xi’an Sonwu Biotech Co., Ltd. The key players are focused on developing advanced anti-infective coatings and dressings to reduce catheter colonization and prevent catheter related infections.
The growing prevalence of hospital acquired infections worldwide is driving the demand for catheter associated blood stream infection prevention and treatment products. According to the Centers for Disease Control and Prevention, over 7,00,000 hospital acquired infections are reported annually in the United States. This is translating into increased adoption of anti-infective solutions in healthcare setups.
Globally, major players in the catheter associated blood stream infection market are expanding their geographical presence with focus on emerging economies in Asia Pacific and Latin America. This is attributed to increasing healthcare infrastructure and expenditure on hospital supplies in developing nations.
Market Key Trends
The increasing usage of antimicrobial coated catheters is a key trend seen in the catheter associated blood stream infection market. Advanced antimicrobial coatings such as chlorhexidine and silver sulfadiazine release antimicrobial agents continuously upon contact with fluids or tissues, inhibiting the growth of microorganisms and preventing infections. Several clinical studies have demonstrated the effectiveness of antimicrobial coated catheters in reducing catheter colonization and blood stream infections significantly compared to traditional catheters. This has propelled the demand for advanced antimicrobial coated devices among healthcare providers.
Porter’s Analysis
Threat of new entrants: The catheter-related bloodstream infection market requires high capital investment for R&D which limits threat of new entrants. Bargaining power of buyers: Individual consumers have low bargaining power whereas large hospitals and healthcare facilities have moderate bargaining power. Bargaining power of suppliers: The catheter-related bloodstream infection market has numerous established global suppliers with specialized products giving them moderate bargaining power. Threat of new substitutes: There exists low threat of substitutes as catheters are essential medical devices with no close substitutes. Competitive rivalry: The market is consolidating with focus on new product innovations, however the overall competition remains high.
Geographical Regions
North America currently holds the largest share of the catheter-related bloodstream infection market in terms of value owing to advanced healthcare infrastructure and high awareness. Asia Pacific is projected to witness the fastest growth over the forecast period due to growing healthcare expenditure, rising medical tourism and increasing demand for advanced treatment options in countries such as China and India.